Stock Research: TransMedics Group

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

TransMedics Group

NasdaqGM:TMDX US89377M1099
43
  • Value
    14
  • Growth
    81
  • Safety
    Safety
    14
  • Combined
    9
  • Sentiment
    82
  • 360° View
    360° View
    43
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

TransMedics Group, Inc. is a medical technology company transforming organ transplant therapy. It specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation using its Organ Care System (OCS) and offers a National OCS Program (NOP) providing outsourced organ procurement and transplant logistics services in the United States. In the last fiscal year, the company had a market cap of $3971 million, profits of $262 million, revenue of $442 million, and 728 employees.

more
Index
NASDAQ
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 15 19 47
Growth
81 99 71 75
Safety
Safety
14 34 65 68
Sentiment
82 54 58 49
360° View
360° View
43 62 76 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
75 64 72 56
Opinions Change
50 50 50 50
Pro Holdings
n/a 33 19 24
Market Pulse
48 67 75 66
Sentiment
82 54 58 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
14 15 19 47
Growth
81 99 71 75
Safety Safety
14 34 65 68
Combined
9 51 65 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
31 29 21 12
Price vs. Earnings (P/E)
23 31 14 41
Price vs. Book (P/B)
11 19 17 56
Dividend Yield
1 1 1 1
Value
14 15 19 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
92 89 96 97
Profit Growth
98 98 61 17
Capital Growth
5 98 6 93
Stock Returns
93 45 85 47
Growth
81 99 71 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
10 7 54 45
Refinancing
41 58 45 65
Liquidity
56 61 50 43
Safety Safety
14 34 65 68

Similar Stocks

Discover high‑ranked alternatives to TransMedics Group and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: